Abstract
Background: Partial breast irradiation (PBI) with targeted intraoperative radiotherapy (TARGIT-IORT) for early stage breast cancer was investigated in TARGIT A trial. However the majority of national guidelines do not consider TARGIT-IORT as a standard PBI modality and additional clinical evidence is necessary. In this study we present “real world” outcome measures of TARGIT-IORT as PBI modality.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
